01 — The Text
What.
- Blocks Medicare, Medicaid, and private insurers from paying for organ transplants performed in China.
- Requires organs to come through the U.S. Organ Procurement and Transplantation Network to qualify for coverage.
- Prohibits U.S. healthcare providers from performing these transplants or related services, with criminal and civil penalties.
02 — The Stakes
So what?
- Affects Americans seeking transplants abroad and hospitals that might perform them; reduces potential access to organs outside U.S. system.
- Targets concerns about organ sourcing practices in China, but may limit options for patients unable to find matches domestically.
- Insurers and providers face legal exposure; enforcement depends on detecting cross-border transplant activity.
03 — The Path
Now what?
- Bill introduced March 2025, referred to two committees (Energy and Commerce, Ways and Means) for review—no hearing or vote scheduled yet.
- Committees must decide jurisdictional split before advancing; passage requires committee approval, floor vote, Senate action, and presidential signature.
- Contact your House representative to share views on transplant access policy.
Legislative History
Actions.
- Mar 14, 2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 14, 2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 14, 2025 — Introduced in House
- Mar 14, 2025 — Introduced in House